CORE MOLDING TECHNOLOGIES IN (CMT) Stock Fundamental Analysis

NYSEARCA:CMT • US2186831002

18.25 USD
-0.92 (-4.8%)
At close: Feb 27, 2026
18.25 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, CMT scores 6 out of 10 in our fundamental rating. CMT was compared to 83 industry peers in the Chemicals industry. CMT gets an excellent profitability rating and is at the same time showing great financial health properties. CMT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CMT was profitable.
  • CMT had a positive operating cash flow in the past year.
  • CMT had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CMT had a positive operating cash flow.
CMT Yearly Net Income VS EBIT VS OCF VS FCFCMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

  • With a decent Return On Assets value of 4.25%, CMT is doing good in the industry, outperforming 75.90% of the companies in the same industry.
  • CMT's Return On Equity of 6.10% is fine compared to the rest of the industry. CMT outperforms 66.27% of its industry peers.
  • The Return On Invested Capital of CMT (5.81%) is better than 65.06% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CMT is above the industry average of 6.18%.
Industry RankSector Rank
ROA 4.25%
ROE 6.1%
ROIC 5.81%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
CMT Yearly ROA, ROE, ROICCMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • With a decent Profit Margin value of 3.39%, CMT is doing good in the industry, outperforming 63.86% of the companies in the same industry.
  • CMT's Profit Margin has improved in the last couple of years.
  • CMT has a Operating Margin of 4.89%. This is comparable to the rest of the industry: CMT outperforms 44.58% of its industry peers.
  • In the last couple of years the Operating Margin of CMT has grown nicely.
  • CMT has a worse Gross Margin (17.50%) than 69.88% of its industry peers.
  • CMT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.89%
PM (TTM) 3.39%
GM 17.5%
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
CMT Yearly Profit, Operating, Gross MarginsCMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • CMT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CMT has less shares outstanding
  • CMT has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CMT has an improved debt to assets ratio.
CMT Yearly Shares OutstandingCMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CMT Yearly Total Debt VS Total AssetsCMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • CMT has an Altman-Z score of 4.24. This indicates that CMT is financially healthy and has little risk of bankruptcy at the moment.
  • CMT's Altman-Z score of 4.24 is amongst the best of the industry. CMT outperforms 91.57% of its industry peers.
  • CMT has a debt to FCF ratio of 1.62. This is a very positive value and a sign of high solvency as it would only need 1.62 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.62, CMT belongs to the top of the industry, outperforming 93.98% of the companies in the same industry.
  • CMT has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.12, CMT belongs to the top of the industry, outperforming 86.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.62
Altman-Z 4.24
ROIC/WACC0.41
WACC14.1%
CMT Yearly LT Debt VS Equity VS FCFCMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 2.85 indicates that CMT has no problem at all paying its short term obligations.
  • CMT has a Current ratio of 2.85. This is amongst the best in the industry. CMT outperforms 81.93% of its industry peers.
  • A Quick Ratio of 2.36 indicates that CMT has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.36, CMT belongs to the best of the industry, outperforming 87.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 2.36
CMT Yearly Current Assets VS Current LiabilitesCMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • CMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.24%.
  • Measured over the past years, CMT shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.08% on average per year.
  • Looking at the last year, CMT shows a very negative growth in Revenue. The Revenue has decreased by -15.48% in the last year.
  • Measured over the past years, CMT shows a small growth in Revenue. The Revenue has been growing by 1.24% on average per year.
EPS 1Y (TTM)-41.24%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-38.89%
Revenue 1Y (TTM)-15.48%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-19.94%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.66% on average over the next years.
  • Based on estimates for the next years, CMT will show a decrease in Revenue. The Revenue will decrease by -2.61% on average per year.
EPS Next Y-22.92%
EPS Next 2Y5.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.09%
Revenue Next 2Y-2.61%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CMT Yearly Revenue VS EstimatesCMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CMT Yearly EPS VS EstimatesCMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2022 2023 2024 2025 2026 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.55 indicates a rather expensive valuation of CMT.
  • Based on the Price/Earnings ratio, CMT is valued a bit cheaper than the industry average as 61.45% of the companies are valued more expensively.
  • CMT is valuated rather cheaply when we compare the Price/Earnings ratio to 27.10, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 10.76, the valuation of CMT can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, CMT is valued cheaply inside the industry as 84.34% of the companies are valued more expensively.
  • CMT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 17.55
Fwd PE 10.76
CMT Price Earnings VS Forward Price EarningsCMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CMT is valued cheaply inside the industry as 95.18% of the companies are valued more expensively.
  • 81.93% of the companies in the same industry are more expensive than CMT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.31
EV/EBITDA 5.33
CMT Per share dataCMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • CMT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.66%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CMT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CORE MOLDING TECHNOLOGIES IN

NYSEARCA:CMT (2/27/2026, 8:04:00 PM)

After market: 18.25 0 (0%)

18.25

-0.92 (-4.8%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-04
Earnings (Next)03-10
Inst Owners78.98%
Inst Owner Change-0.19%
Ins Owners5.34%
Ins Owner Change-4.59%
Market Cap156.22M
Revenue(TTM)302.38M
Net Income(TTM)9.36M
Analysts80
Price Target22.44 (22.96%)
Short Float %1.84%
Short Ratio5.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.54%
Min EPS beat(2)-12.99%
Max EPS beat(2)14.08%
EPS beat(4)2
Avg EPS beat(4)-10.99%
Min EPS beat(4)-100%
Max EPS beat(4)54.97%
EPS beat(8)5
Avg EPS beat(8)49.77%
EPS beat(12)8
Avg EPS beat(12)73.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.58%
Min Revenue beat(2)-11.13%
Max Revenue beat(2)3.97%
Revenue beat(4)3
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-11.13%
Max Revenue beat(4)5.25%
Revenue beat(8)5
Avg Revenue beat(8)0.53%
Revenue beat(12)8
Avg Revenue beat(12)3.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2%
Valuation
Industry RankSector Rank
PE 17.55
Fwd PE 10.76
P/S 0.57
P/FCF 12.31
P/OCF 6.56
P/B 1.02
P/tB 1.18
EV/EBITDA 5.33
EPS(TTM)1.04
EY5.7%
EPS(NY)1.7
Fwd EY9.3%
FCF(TTM)1.48
FCFY8.13%
OCF(TTM)2.78
OCFY15.24%
SpS32.26
BVpS17.93
TBVpS15.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.48
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 6.1%
ROCE 7.49%
ROIC 5.81%
ROICexc 7.64%
ROICexgc 9.05%
OM 4.89%
PM (TTM) 3.39%
GM 17.5%
FCFM 4.6%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
ROICexc(3y)11.4%
ROICexc(5y)9.43%
ROICexgc(3y)13.69%
ROICexgc(5y)11.53%
ROCE(3y)12.62%
ROCE(5y)10.78%
ROICexgc growth 3Y14.36%
ROICexgc growth 5YN/A
ROICexc growth 3Y16.49%
ROICexc growth 5YN/A
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
F-Score7
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.62
Debt/EBITDA 0.71
Cap/Depr 85.03%
Cap/Sales 4.02%
Interest Coverage 12.8
Cash Conversion 89.59%
Profit Quality 135.69%
Current Ratio 2.85
Quick Ratio 2.36
Altman-Z 4.24
F-Score7
WACC14.1%
ROIC/WACC0.41
Cap/Depr(3y)98.69%
Cap/Depr(5y)85.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.23%
Profit Quality(3y)108.24%
Profit Quality(5y)132.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-41.24%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-38.89%
EPS Next Y-22.92%
EPS Next 2Y5.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.48%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-19.94%
Revenue Next Year-11.09%
Revenue Next 2Y-2.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.48%
EBIT growth 3Y17.56%
EBIT growth 5YN/A
EBIT Next Year77.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.49%
FCF growth 3Y189.18%
FCF growth 5Y20.65%
OCF growth 1Y-31.88%
OCF growth 3Y40.98%
OCF growth 5Y16.05%

CORE MOLDING TECHNOLOGIES IN / CMT FAQ

Can you provide the ChartMill fundamental rating for CORE MOLDING TECHNOLOGIES IN?

ChartMill assigns a fundamental rating of 6 / 10 to CMT.


What is the valuation status for CMT stock?

ChartMill assigns a valuation rating of 6 / 10 to CORE MOLDING TECHNOLOGIES IN (CMT). This can be considered as Fairly Valued.


How profitable is CORE MOLDING TECHNOLOGIES IN (CMT) stock?

CORE MOLDING TECHNOLOGIES IN (CMT) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for CMT stock?

The Price/Earnings (PE) ratio for CORE MOLDING TECHNOLOGIES IN (CMT) is 17.55 and the Price/Book (PB) ratio is 1.02.


How financially healthy is CORE MOLDING TECHNOLOGIES IN?

The financial health rating of CORE MOLDING TECHNOLOGIES IN (CMT) is 9 / 10.